Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic disease of the joints that can cause a disabling degree of pain and significantly interfere with an individual’s day-to-day living.

What is Rheumatoid Arthritis?

Rheumatoid arthritis or RA is an inflammatory condition that affects joints primarily leading to pain and stiffness and difficulty in movements. Commonly affected joints are those of the hands, feet and wrists. RA however can also affect other parts of the body.

What Causes Rheumatoid Arthritis?

Rheumatoid Arthritis Symptoms

Rheumatoid Arthritis Diagnosis

Are There Any Natural Remedies for Rheumatoid Arthritis?

Rheumatoid Factor Test

Knee Rheumatoid Arthritis

Total Knee Replacement and Rheumatoid Arthritis

Hip Rheumatoid Arthritis

Rheumatoid Arthritis and Feet

Rheumatoid Arthritis and Pregnancy

Rheumatoid Arthritis, Family Planning & Pregnancy

See more featured articles »

Rheumatoid Arthritis and Gum Disease

Rheumatoid Arthritis and Depression

Rheumatoid Arthritis and Gout

Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis Symptoms

Juvenile Rheumatoid Arthritis Types

Juvenile Rheumatoid Arthritis Diagnosis

Juvenile Rheumatoid Arthritis Treatment

Rheumatoid Arthritis Nodules

Rheumatoid Arthritis and Winter Weather

Rheumatoid Arthritis Treatment

Disease-Modifying AntiRheumatic Drugs (DMARDs)

Rheumatoid Arthritis Management

Radiotherapy and Rheumatoid Arthritis

Rheumatoid Arthritis and Acupuncture

Yoga and Tai chi in Rheumatoid Arthritis

Rheumatoid Arthritis and Exercise

Rheumatoid Arthritis Diet and Nutrition

Self-Help and Living with Rheumatoid Arthritis

Rheumatoid Arthritis Research

Rheumatoid Arthritis Support

Rheumatoid Arthritis Prognosis

Rheumatoid Arthritis Complications

Rheumatoid Arthritis Epidemiology

Rheumatoid Arthritis Skin Problems

Rheumatoid Arthritis History

Causes of Hand Pain

Rheumatoid Arthritis and Vitamin D

Psoriatic Arthritis vs Rheumatoid Arthritis

Can Antibiotics Increase the Risk of Arthritis?

Latest Rheumatoid Arthritis News and Research

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Scientists have developed a 'nanobody' - a small fragment of a llama antibody - that is capable of chasing out human cytomegalovirus (HCMV) as it hides away from the immune system.

22 Jul 2021

Study: Diet rich in fermented foods boosts microbial diversity, decreases inflammation

A diet rich in fermented foods enhances the diversity of gut microbes and decreases molecular signs of inflammation, according to researchers at the Stanford School of Medicine.

12 Jul 2021

Drugmakers’ spending on stock, dividends and executive pay exceeds research, democrats say

The largest drug companies are far more interested in enriching themselves and investors than in developing new drugs, according to a House committee report released Thursday that argues the industry can afford to charge Medicare less for prescriptions.

9 Jul 2021

Anti-rheumatic drug combinations could reduce the risk of heart attack and strokes

New research evaluating the drugs commonly used by rheumatoid arthritis patients suggests two combinations could reduce the risk of heart attack and strokes.

6 Jul 2021

NYU Abu Dhabi researchers use NMR spectroscopy to map the structure of specific nanobody

For the first time in the UAE, researchers at NYU Abu Dhabi have used nuclear magnetic resonance techniques to determine the structure of a specific nanobody, Nb23, potentially leading to a better understanding of how this small protein derived from an antibody type, found only in camelids (i.e camels, llamas, and alpacas) and sharks, can fight diseases ranging from rheumatoid arthritis, lupus and psoriasis to lymphoma and breast cancer.

2 Jul 2021

New microchip can measure stress hormones in real time from a drop of blood

A Rutgers-led team of researchers has developed a microchip that can measure stress hormones in real time from a drop of blood.

1 Jul 2021

Exploring young people’s perspectives on patient-reported outcome measures in inflammatory arthritis

Inflammatory arthritis is the name for a group of diseases that cause joint pain and swelling. This happens because the body's immune system attacks its own tissues and causes inflammation.

23 Jun 2021

New recommendations on the use of intra-articular therapies

Intra-articular therapies (IAT) are frequently used to treat joint conditions such as gout, rheumatoid arthritis, or osteoarthritis.

23 Jun 2021

Repurposing immunomodulatory drugs to treat COVID-19

EULAR has released new points to consider on the use of immunomodulatory drugs in the fight against severe COVID-19.

23 Jun 2021

Effect of national tender system on the costs of biologic and targeted drugs in Norway

At the 2021 EULAR congress, Brkic and colleagues presented data from people with rheumatoid arthritis (RA)treated at Norwegian rheumatology outpatient clinics between 2010 and 2019.

21 Jun 2021

Baseline use of DMARDs linked with COVID-19 severity in rheumatoid arthritis patients

Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome- for example, the risk of hospitalization.

18 Jun 2021

New guidance provides valuable direction in the clinical use of HR-pQCT imaging

In recent years, significant progress has been made towards the use of high-resolution peripheral computed tomography (HR-pQCT) imaging in research, and new potential for applications in the clinic have emerged, particularly with the advent of second generation devices.

18 Jun 2021

Chronic fatigue a significant challenge for most long COVID patients

Researchers in Canada have conducted a study suggesting that the majority of patients living with long COVID (coronavirus disease) following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience chronic fatigue that is at least as severe as that seen in several other clinical conditions.

15 Jun 2021

Forkhead box O's potential therapeutic use in the treatment of COVID-19

In a recent study, Indian researchers from the Department of Biochemistry, University of Delhi, reviewed a possible vital coalition of FoxOs - the Forkhead Box O subfamily of protein transcription factors, with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the etiological agent of COVID-19 (coronavirus disease).

13 Jun 2021

Microgel-coated mesenchymal stromal cells can reverse pulmonary fibrosis

Researchers at the University of Illinois Chicago have shown that even after lung tissue has been damaged, it may be possible to reverse fibrosis and promote tissue repair through treatment with microgel-coated mesenchymal stromal cells.

9 Jun 2021

What is the role of monoclonal antibody therapy in treating COVID-19?

A new study has been published in the journal Vaccines that deals with the present state of research on using mAbs for the treatment of the COVID-19 disease. Many clinical trials are being conducted to evaluate the efficacy and safety of several newly designed mAbs. Some of the mAbs are directed towards immune system responses, i.e., non-SARS-CoV-2 specific mAbs, while others are devised to neutralize the SARS-CoV-2 protein structure, i.e., SARS-CoV-2 specific mAbs.

8 Jun 2021

Methotrexate users fail to achieve adequate immune response to mRNA COVID-19 vaccines

Up to a third of patients taking methotrexate – a common treatment for immune mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis – failed to achieve an adequate immune response to mRNA COVID-19 vaccines in a small study accepted for publication in the journal Annals of the Rheumatic Diseases.

4 Jun 2021

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

However, a fascinating new study posted to the medRxiv* preprint server suggests that such disappointment may have been both premature and unwarranted, based on a re-analysis of over 250 patients on invasive mechanical ventilation (IMV) during the first two months of the pandemic.

2 Jun 2021

People taking anti-inflammatory drug mount a weaker immune response to COVID-19 vaccine

One-quarter of people who take the drug methotrexate for common immune system disorders -- from rheumatoid arthritis to multiple sclerosis -- mount a weaker immune response to a COVID-19 vaccine, a new study shows.

2 Jun 2021

Little-known illnesses turning up in Covid long-haulers

The day Dr. Elizabeth Dawson was diagnosed with covid-19 in October, she awoke feeling as if she had a bad hangover. Four months later she tested negative for the virus, but her symptoms have only worsened.

1 Jun 2021